Piyush Gordhanbhai Antala
About Piyush Gordhanbhai Antala
Data last updated:
Piyush Gordhanbhai Antala is a Whole-Time Director at Curis Lifesciences Limited (since 2016). The company operates in Chemicals. Curis Lifesciences Limited reported revenue of ₹35.98 Cr (FY 2024).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Curis Lifesciences Limited L24230GJ2016PLC086559 | Whole-Time Director | 23 Mar 2016 | 2016 | ₹35.98 Cr (FY 2024) | Active |
Board colleagues of Piyush Gordhanbhai Antala
| Name | DIN | Company | Designation |
|---|---|---|---|
| Devabhai Hamirbhai Jadeja | 11604996 | Curis Lifesciences Limited | Director |
| Dharmesh Dasharathbhai Patel | 07371033 | Curis Lifesciences Limited | Managing Director |
| Grishma A Shewale | 10685826 | Curis Lifesciences Limited | Director |
| Jaimik Mansukhlal Patel | 07371003 | Curis Lifesciences Limited | Whole-Time Director |
| Pragnesh Radheshyam Sharma | Curis Lifesciences Limited | Cfo | |
| Siddhant Jayantibhai Pawasia | 07371060 | Curis Lifesciences Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Piyush Gordhanbhai Antala
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Piyush Gordhanbhai Antala
Piyush Gordhanbhai Antala currently holds 1 directorship: Curis Lifesciences Limited (Whole-Time Director, since 23 Mar 2016, revenue ₹35.98 Cr (FY 2024)).
Piyush Gordhanbhai Antala was first appointed on 23 Mar 2016 as Whole-Time Director at Curis Lifesciences Limited.
The current boards of Piyush Gordhanbhai Antala's companies include Devabhai Hamirbhai Jadeja (Curis Lifesciences Limited), Dharmesh Dasharathbhai Patel (Curis Lifesciences Limited), Grishma A Shewale (Curis Lifesciences Limited), Jaimik Mansukhlal Patel (Curis Lifesciences Limited), Pragnesh Radheshyam Sharma (Curis Lifesciences Limited), Siddhant Jayantibhai Pawasia (Curis Lifesciences Limited).